U.S. pharma big copyright scrapped two experimental weight loss drugs final 12 months—a as soon as-each day capsule, lotiglipron, as a result of elevated liver enzymes in addition to a twice-everyday pill, danuglipron, on account of strong Unwanted side effects—but CEO Albert Bourla has claimed the company is set to “Enjoy and gain” within